Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin Regimen for Patients Infected with Chronic Hepatitis C Virus Genotype 1 in Malaysia

Clicks: 268
ID: 92158
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
shafie2020costeffectivenessvalue Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shafie, A.
Journal value in health regional issues
Year 2020
DOI
10.1016/j.vhri.2019.09.005
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.